Prostate carcinoma is the second most frequent cause of cancer-related death in men. MR imaging, with T2-weighted scans, MR spectroscopy, dynamic contrast enhancement and diffusion weighted imaging is seen as a method that can improve prostate cancer detection, characterization, staging, and treatment follow-up.